CVS · CUSIP 126650100
CVS HEALTH CORP
Reported by 10 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-08-24.
- Managers holding
- 10
- Average portfolio weight
- 3.3%
- Combined reported value
- $8.5B
- Research group
- 79
10 of the 79 superinvestors Shameless Cloning tracks reported CVS HEALTH CORP (CVS) in their Q2 2026 13F filings, worth $8.5B combined, at an average 3.3% of their portfolios. The largest positions by portfolio weight belong to Prem Watsa (10.6%), Christopher Davis (5.3%), Samantha McLemore (4.2%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Prem WatsaFAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 10.6% | $280.5M |
| Christopher DavisDavis Selected Advisers | 5.3% | $1.2B |
| Samantha McLemorePatient Capital Management, LLC | 4.2% | $127.8M |
| Hillman Capital ManagementHillman Capital Management, Inc. | 4.2% | $5.7M |
| Richard PzenaPZENA INVESTMENT MANAGEMENT LLC | 3.6% | $1.2B |
| Dodge & Cox FundsDodge & Cox | 2.7% | $5.2B |
| Viking Global InvestorsVIKING GLOBAL INVESTORS LP | 1.1% | $379.0M |
| John RogersARIEL INVESTMENTS, LLC | 0.8% | $75.5M |
| David KatzMATRIX ASSET ADVISORS INC/NY | 0.1% | $639K |
| Bill NygrenHARRIS ASSOCIATES L P | 0.0% | $34.7M |